Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial

Colin P. Derdeyn, David Fiorella, Michael J. Lynn, Stanley L. Barnwell, Osama Zaidat, Philip M. Meyers, Y. Pierre Gobin, Jacques Dion, Bethany F. Lane, Tanya N. Turan, L. Scott Janis, Marc I. Chimowitz

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background and purpose To investigate the relationship between physician and site experience and the risk of 30 day hemorrhagic and ischemic strokes in the stenting arm of the Stenting and Aggressive Medical Management for the Prevention of Recurrent Ischemic Stroke (SAMMPRIS) trial. Methods Study records and an investigator survey were examined for physician and site related factors, including: number of Wingspan and aneurysm stents submitted for credentialing, number of study procedures performed in SAMMPRIS, years in practice after training, primary specialty, and site enrollment. Bivariate and multivariate analyses were performed to determine if these factors were associated with the 30 day rate of cerebrovascular events after angioplasty and stenting. Results 213 patients underwent angioplasty alone (n=5) or angioplasty and stenting (n=208) with study devices by 63 interventionists at 48 sites. For credentialing, the median number of Wingspan and similar aneurysm stent cases submitted by study interventionists were 10 and 6, respectively. Interventionists with higher numbers (>10) of Wingspan cases submitted for credentialing tended to have higher rates of 30 day events (19.0% vs 9.9%) than those with 12 patients). Conclusions Interventionists credentialed with less Wingspan experience were not responsible for the high rate of periprocedural stroke in SAMMPRIS. Hemorrhagic stroke may be related to low enrollment in the trial but not previous Wingspan experience.

Original languageEnglish (US)
Pages (from-to)528-533
Number of pages6
JournalJournal of NeuroInterventional Surgery
Volume5
Issue number6
DOIs
StatePublished - Nov 2013

Fingerprint

Angioplasty
Stroke
Credentialing
Stents
Aneurysm
Physicians
Multivariate Analysis
Research Personnel
Equipment and Supplies

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Derdeyn, C. P., Fiorella, D., Lynn, M. J., Barnwell, S. L., Zaidat, O., Meyers, P. M., ... Chimowitz, M. I. (2013). Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial. Journal of NeuroInterventional Surgery, 5(6), 528-533. https://doi.org/10.1136/neurintsurg-2012-010504

Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial. / Derdeyn, Colin P.; Fiorella, David; Lynn, Michael J.; Barnwell, Stanley L.; Zaidat, Osama; Meyers, Philip M.; Gobin, Y. Pierre; Dion, Jacques; Lane, Bethany F.; Turan, Tanya N.; Janis, L. Scott; Chimowitz, Marc I.

In: Journal of NeuroInterventional Surgery, Vol. 5, No. 6, 11.2013, p. 528-533.

Research output: Contribution to journalArticle

Derdeyn, CP, Fiorella, D, Lynn, MJ, Barnwell, SL, Zaidat, O, Meyers, PM, Gobin, YP, Dion, J, Lane, BF, Turan, TN, Janis, LS & Chimowitz, MI 2013, 'Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial', Journal of NeuroInterventional Surgery, vol. 5, no. 6, pp. 528-533. https://doi.org/10.1136/neurintsurg-2012-010504
Derdeyn, Colin P. ; Fiorella, David ; Lynn, Michael J. ; Barnwell, Stanley L. ; Zaidat, Osama ; Meyers, Philip M. ; Gobin, Y. Pierre ; Dion, Jacques ; Lane, Bethany F. ; Turan, Tanya N. ; Janis, L. Scott ; Chimowitz, Marc I. / Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial. In: Journal of NeuroInterventional Surgery. 2013 ; Vol. 5, No. 6. pp. 528-533.
@article{77021ee51a174deeb3af33fe6a3bce42,
title = "Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial",
abstract = "Background and purpose To investigate the relationship between physician and site experience and the risk of 30 day hemorrhagic and ischemic strokes in the stenting arm of the Stenting and Aggressive Medical Management for the Prevention of Recurrent Ischemic Stroke (SAMMPRIS) trial. Methods Study records and an investigator survey were examined for physician and site related factors, including: number of Wingspan and aneurysm stents submitted for credentialing, number of study procedures performed in SAMMPRIS, years in practice after training, primary specialty, and site enrollment. Bivariate and multivariate analyses were performed to determine if these factors were associated with the 30 day rate of cerebrovascular events after angioplasty and stenting. Results 213 patients underwent angioplasty alone (n=5) or angioplasty and stenting (n=208) with study devices by 63 interventionists at 48 sites. For credentialing, the median number of Wingspan and similar aneurysm stent cases submitted by study interventionists were 10 and 6, respectively. Interventionists with higher numbers (>10) of Wingspan cases submitted for credentialing tended to have higher rates of 30 day events (19.0{\%} vs 9.9{\%}) than those with 12 patients). Conclusions Interventionists credentialed with less Wingspan experience were not responsible for the high rate of periprocedural stroke in SAMMPRIS. Hemorrhagic stroke may be related to low enrollment in the trial but not previous Wingspan experience.",
author = "Derdeyn, {Colin P.} and David Fiorella and Lynn, {Michael J.} and Barnwell, {Stanley L.} and Osama Zaidat and Meyers, {Philip M.} and Gobin, {Y. Pierre} and Jacques Dion and Lane, {Bethany F.} and Turan, {Tanya N.} and Janis, {L. Scott} and Chimowitz, {Marc I.}",
year = "2013",
month = "11",
doi = "10.1136/neurintsurg-2012-010504",
language = "English (US)",
volume = "5",
pages = "528--533",
journal = "Journal of NeuroInterventional Surgery",
issn = "1759-8478",
publisher = "BMJ Publishing Group",
number = "6",

}

TY - JOUR

T1 - Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial

AU - Derdeyn, Colin P.

AU - Fiorella, David

AU - Lynn, Michael J.

AU - Barnwell, Stanley L.

AU - Zaidat, Osama

AU - Meyers, Philip M.

AU - Gobin, Y. Pierre

AU - Dion, Jacques

AU - Lane, Bethany F.

AU - Turan, Tanya N.

AU - Janis, L. Scott

AU - Chimowitz, Marc I.

PY - 2013/11

Y1 - 2013/11

N2 - Background and purpose To investigate the relationship between physician and site experience and the risk of 30 day hemorrhagic and ischemic strokes in the stenting arm of the Stenting and Aggressive Medical Management for the Prevention of Recurrent Ischemic Stroke (SAMMPRIS) trial. Methods Study records and an investigator survey were examined for physician and site related factors, including: number of Wingspan and aneurysm stents submitted for credentialing, number of study procedures performed in SAMMPRIS, years in practice after training, primary specialty, and site enrollment. Bivariate and multivariate analyses were performed to determine if these factors were associated with the 30 day rate of cerebrovascular events after angioplasty and stenting. Results 213 patients underwent angioplasty alone (n=5) or angioplasty and stenting (n=208) with study devices by 63 interventionists at 48 sites. For credentialing, the median number of Wingspan and similar aneurysm stent cases submitted by study interventionists were 10 and 6, respectively. Interventionists with higher numbers (>10) of Wingspan cases submitted for credentialing tended to have higher rates of 30 day events (19.0% vs 9.9%) than those with 12 patients). Conclusions Interventionists credentialed with less Wingspan experience were not responsible for the high rate of periprocedural stroke in SAMMPRIS. Hemorrhagic stroke may be related to low enrollment in the trial but not previous Wingspan experience.

AB - Background and purpose To investigate the relationship between physician and site experience and the risk of 30 day hemorrhagic and ischemic strokes in the stenting arm of the Stenting and Aggressive Medical Management for the Prevention of Recurrent Ischemic Stroke (SAMMPRIS) trial. Methods Study records and an investigator survey were examined for physician and site related factors, including: number of Wingspan and aneurysm stents submitted for credentialing, number of study procedures performed in SAMMPRIS, years in practice after training, primary specialty, and site enrollment. Bivariate and multivariate analyses were performed to determine if these factors were associated with the 30 day rate of cerebrovascular events after angioplasty and stenting. Results 213 patients underwent angioplasty alone (n=5) or angioplasty and stenting (n=208) with study devices by 63 interventionists at 48 sites. For credentialing, the median number of Wingspan and similar aneurysm stent cases submitted by study interventionists were 10 and 6, respectively. Interventionists with higher numbers (>10) of Wingspan cases submitted for credentialing tended to have higher rates of 30 day events (19.0% vs 9.9%) than those with 12 patients). Conclusions Interventionists credentialed with less Wingspan experience were not responsible for the high rate of periprocedural stroke in SAMMPRIS. Hemorrhagic stroke may be related to low enrollment in the trial but not previous Wingspan experience.

UR - http://www.scopus.com/inward/record.url?scp=84885360899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885360899&partnerID=8YFLogxK

U2 - 10.1136/neurintsurg-2012-010504

DO - 10.1136/neurintsurg-2012-010504

M3 - Article

VL - 5

SP - 528

EP - 533

JO - Journal of NeuroInterventional Surgery

JF - Journal of NeuroInterventional Surgery

SN - 1759-8478

IS - 6

ER -